Sign up to save your podcasts
Or
Share Gene Therapy for X-Linked Retinitis Pigmentosa
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gene Therapy for X-Linked Retinitis Pigmentosa
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,446 Listeners
The Daily
112,617 Listeners
WSJ Minute Briefing
670 Listeners
Up First from NPR
56,456 Listeners
Bogleheads On Investing Podcast
594 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
707 Listeners